← Back to Search

Screening (questionnaire, biospecimen collection) for Prostate Cancer

N/A
Recruiting
Research Sponsored by Alliance for Clinical Trials in Oncology
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 1 year
Awards & highlights

Summary

This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the early detection of cancers.

Eligible Conditions
  • Prostate Cancer
  • Lung Cancer
  • Bladder Cancer
  • Breast Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Uterine Corpus Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Esophageal Cancer
  • Uterine Cancer
  • Acute Lymphoblastic Leukemia
  • Chronic Lymphocytic Leukemia
  • Leukemia
  • Gastroesophageal Junction Adenocarcinoma
  • Head and Neck Cancers
  • Blood Cancers
  • Kidney Cancer
  • Liver and Bile Duct Tumors
  • Cancer
  • Melanoma
  • Multiple Myeloma
  • Sarcoma
  • Thyroid Cancer
  • Acute Myeloid Leukemia
  • Lymphoma

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Provision of blinded reference set of cancer versus non-cancer blood samples
Secondary outcome measures
Test performance at the time of initial cancer diagnosis by clinical stage
Test performance at the time of initial cancer diagnosis by tumor type

Trial Design

1Treatment groups
Experimental Treatment
Group I: Screening (questionnaire, biospecimen collection)Experimental Treatment2 Interventions
Participants complete a questionnaire at baseline. Participants undergo collection of blood samples at registration and at 12 months after registration. Patients with a cancer diagnosis may undergo collection of tissue samples at registration and 12 months after registration.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Biospecimen Collection
2004
Completed Phase 3
~2020

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,842 Previous Clinical Trials
41,001,000 Total Patients Enrolled
567 Trials studying Prostate Cancer
529,809 Patients Enrolled for Prostate Cancer
Alliance for Clinical Trials in OncologyLead Sponsor
512 Previous Clinical Trials
215,472 Total Patients Enrolled
30 Trials studying Prostate Cancer
5,924 Patients Enrolled for Prostate Cancer
Marie Wood, MDStudy ChairUniversity of Colorado, Denver
2 Previous Clinical Trials
48 Total Patients Enrolled
~276 spots leftby Jan 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top